Journal Article
Gefitinib induces apoptosis and decreases telomerase activity in MDA-MB-231 human breast cancer cells
Dong-Oh Moon, Mun-Ock Kim, Moon-Soo Heo, Jae-Dong Lee and Yung Hyun Choi, et al.
Archives of Pharmacal Research, 2009, Volume 32, Number 10, Pages 1351-1360
Book Chapter
Tyrosine Kinase Inhibitors and Cancer Therapy
Srinivasan Madhusudan and Trivadi Ganesan
Recent Results in Cancer Research, 1, Volume 172, Targeted Interference with Signal Transduction Events, Pages 25-44
Journal Article
Inhibition of HER1 signaling pathway enhances antitumor effect of endocrine therapy in breast cancer
Junichi Kurebayashi, Sumiko Okubo, Yutaka Yamamoto and Hiroshi Sonoo
Breast Cancer, 2004, Volume 11, Number 1, Pages 38-41
Journal Article
A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer
Gunter von Minckwitz, Walter Jonat, Peter Fasching, Andreas du Bois and Ulrich Kleeberg, et al.
Breast Cancer Research and Treatment, 2005, Volume 89, Number 2, Pages 165-172
Book Chapter
Clinical Development of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors: What Lessons Have We Learned?
Manuel Hidalgo
Advances in Experimental Medicine and Biology, 1, Volume 610, Targeted Therapies in Cancer, Pages 128-143
Book Chapter
Mechanisms of Resistance to Targeted Tyrosine Kinase Inhibitors
Stacey J. Baker and E. Premkumar Reddy
2009, Drug Resistance in Cancer Cells, Pages 73-93
Journal Article
ErbB tyrosine kinase receptor inhibitors in breast cancer treatment
Joan Albanell Mestres, Montserrat Muñoz Mateo and Pedro Gascón
Clinical and Translational Oncology, 2004, Volume 6, Number 1, Pages 12-21
Journal Article
Pharmacodynamics: biological activity of targeted therapies in clinical trials
F. Rojo, A. Dalmases, J. M. Corominas and J. Albanell
Clinical and Translational Oncology, 2007, Volume 9, Number 10, Pages 634-644
Book Chapter
Clinical Trial Design with Targeted Agents
Sarita Dubey and Joan H. Schiller
Cancer Drug Discovery and Development, 2008, Molecular Targeting in Oncology, V, Pages 649-655
Journal Article
Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells
Amelia D’Alessio, Antonella De Luca, Monica R. Maiello, Luana Lamura and Anna Maria Rachiglio, et al.
Breast Cancer Research and Treatment, 2010, Volume 123, Number 2, Pages 387-396